[Skip to Navigation]
Sign In

October 2021 - July 1883

Decade

Year

Issue

March 27, 2013, Vol 309, No. 12, Pages 1201-1306

This Week in JAMA

This Week in JAMA

Abstract Full Text
free access has audio
JAMA. 2013;309(12):1201. doi:10.1001/jama.2012.145324
Viewpoint

ONLINE FIRST

A Systematic Plan for Firearms Law Reform

Abstract Full Text
JAMA. 2013;309(12):1231-1232. doi:10.1001/jama.2013.1127

ONLINE FIRST

Mental Illness and New Gun Law Reforms: The Promise and Peril of Crisis-Driven Policy

Abstract Full Text
JAMA. 2013;309(12):1233-1234. doi:10.1001/jama.2013.1113

The Economics of Genomic Medicine: Insights From the IOM Roundtable on Translating Genomic-Based Research for Health

Abstract Full Text
JAMA. 2013;309(12):1235-1236. doi:10.1001/jama.2013.113

ONLINE FIRST

Crossing the Omic Chasm: A Time for Omic Ancillary Systems

Abstract Full Text
JAMA. 2013;309(12):1237-1238. doi:10.1001/jama.2013.1579
A Piece of My Mind

The NRA Let Me Down

Abstract Full Text
JAMA. 2013;309(12):1239-1240. doi:10.1001/jama.2013.1302
Original Contribution

Effect of Disodium EDTA Chelation Regimen on Cardiovascular Events in Patients With Previous Myocardial Infarction: The TACT Randomized Trial

Abstract Full Text
free access has multimedia has audio
JAMA. 2013;309(12):1241-1250. doi:10.1001/jama.2013.2107

Lamas et al report results of the Trial to Assess Chelation Therapy (TACT), a randomized controlled trial analyzing whether EDTA-based chelation therapy reduced cardiovascular events in 1708 patients with a history of myocardial infarction. In editorials, Nissen and Bauchner et al discuss the evaluation of TACT.

Effect of Azithromycin Maintenance Treatment on Infectious Exacerbations Among Patients With Non–Cystic Fibrosis Bronchiectasis: The BAT Randomized Controlled Trial

Abstract Full Text
free access
JAMA. 2013;309(12):1251-1259. doi:10.1001/jama.2013.1937

To determine the efficacy of macrolide maintenance treatment for adults with non–cystic fibrosis bronchiectasis, Altenburg and coauthors randomized 83 outpatients with 3 or more lower respiratory tract infections in the preceding year to receive azithromycin or placebo for 12 months. Elborn and Tunney provide comment in the related Editorial.

Effect of Long-term, Low-Dose Erythromycin on Pulmonary Exacerbations Among Patients With Non–Cystic Fibrosis Bronchiectasis: The BLESS Randomized Controlled Trial

Abstract Full Text
free access
JAMA. 2013;309(12):1260-1267. doi:10.1001/jama.2013.2290

Serisier and coauthors evaluate the clinical efficacy and antimicrobial resistance cost of low-dose erythromycin for patients with non–cystic fibrosis bronchiectasis in a 12-month, double-blind, placebo-controlled trial. In an Editorial, Elborn and Tunney discuss long-term macrolide therapy for patients with bronchiectasis.

ONLINE FIRST

Effect of Phosphodiesterase-5 Inhibition on Exercise Capacity and Clinical Status in Heart Failure With Preserved Ejection Fraction: A Randomized Clinical Trial

Abstract Full Text
free access
JAMA. 2013;309(12):1268-1277. doi:10.1001/jama.2013.2024

To determine the effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction, Redfield and coauthors conducted a trial of 216 patients randomized to sildenafil or placebo and measured peak oxygen consumption along with a variety of clinical status variables.

Editorial

Evaluation of the Trial to Assess Chelation Therapy (TACT): The Scientific Process, Peer Review, and Editorial Scrutiny

Abstract Full Text
free access
JAMA. 2013;309(12):1291-1292. doi:10.1001/jama.2013.2761

Concerns About Reliability in the Trial to Assess Chelation Therapy (TACT)

Abstract Full Text
free access
JAMA. 2013;309(12):1293-1294. doi:10.1001/jama.2013.2778

Macrolides and Bronchiectasis: Clinical Benefit With a Resistance Price

Abstract Full Text
JAMA. 2013;309(12):1295-1296. doi:10.1001/jama.2013.2780

Is Sublingual Immunotherapy Ready for Use in the United States?

Abstract Full Text
JAMA. 2013;309(12):1297-1298. doi:10.1001/jama.2013.2739
JAMA Clinical Challenge

Clinician's Corner

A 51-Year-Old Man With HIV and Cervicodorsal Lipodystrophy (Buffalo Hump)

Abstract Full Text
JAMA. 2013;309(12):1289-1290. doi:10.1001/jama.2013.2552
Medical News & Perspectives

After 50 Years, Newborn Screening Continues to Yield Public Health Gains

Abstract Full Text
JAMA. 2013;309(12):1215-1217. doi:10.1001/jama.2013.2087

Studies Probe Restoring Speech in Persons With Chronic Stroke-Related Aphasia

Abstract Full Text
JAMA. 2013;309(12):1217-1218. doi:10.1001/jama.2013.1253
Visualizing Health Policy

Medicaid Expansion Under the Affordable Care Act

Abstract Full Text
free access
JAMA. 2013;309(12):1219. doi:10.1001/jama.2013.2481
News From the Centers for Disease Control and Prevention
Health Agencies Update

Fungal Infection in Florida

Abstract Full Text
JAMA. 2013;309(12):1220. doi:10.1001/jama.2013.2584

Retinal Implant

Abstract Full Text
JAMA. 2013;309(12):1220. doi:10.1001/jama.2013.2714

Teens and Substance Use

Abstract Full Text
JAMA. 2013;309(12):1220. doi:10.1001/jama.2013.2716

Glucose During Pregnancy

Abstract Full Text
JAMA. 2013;309(12):1220. doi:10.1001/jama.2013.2718
Letters

Warfarin Treatment After Bioprosthetic Aortic Valve Replacement

Abstract Full Text
JAMA. 2013;309(12):1225-1226. doi:10.1001/jama.2013.1972

Warfarin Treatment After Bioprosthetic Aortic Valve Replacement—Reply

Abstract Full Text
JAMA. 2013;309(12):1225-1226. doi:10.1001/jama.2013.1978

Aspirin Use and Risk of Macular Degeneration

Abstract Full Text
JAMA. 2013;309(12):1226. doi:10.1001/jama.2013.2038

Aspirin Use and Risk of Macular Degeneration

Abstract Full Text
JAMA. 2013;309(12):1227-1228. doi:10.1001/jama.2013.2035

Aspirin Use and Risk of Macular Degeneration—Reply

Abstract Full Text
JAMA. 2013;309(12):1227-1228. doi:10.1001/jama.2013.2041

Funding for Biomedical Research

Abstract Full Text
JAMA. 2013;309(12):1228-1229. doi:10.1001/jama.2013.1331

Funding for Biomedical Research—Reply

Abstract Full Text
JAMA. 2013;309(12):1228-1229. doi:10.1001/jama.2013.1346
The Cover

Easter Sunday

Abstract Full Text
JAMA. 2013;309(12):1205. doi:10.1001/jama.2012.176795
Poetry and Medicine

Virtual White Coat

Abstract Full Text
JAMA. 2013;309(12):1206. doi:10.1001/jama.2012.71220
JAMA Patient Page

Treatment of Varicose Veins

Abstract Full Text
free access
JAMA. 2013;309(12):1306. doi:10.1001/jama.2013.1704
JAMA Masthead

About This Journal

Abstract Full Text
free access
JAMA. 2013;309(12):1203. doi:10.1001/jama.309.12.1203
Clinical Review

Sublingual Immunotherapy for the Treatment of Allergic Rhinoconjunctivitis and Asthma: A Systematic Review

Abstract Full Text
free access
JAMA. 2013;309(12):1278-1288. doi:10.1001/jama.2013.2049

Lin and coauthors report on the use of sublingual immunotherapy as a treatment for allergic rhinoconjunctivitis and asthma. In an accompanying Editorial, Nelson discusses whether sublingual immuotherapy is ready for use in the United States.

JAMA 100 Years Ago

THE RATTLESNAKE-VENOM TREATMENT OF EPILEPSY

Abstract Full Text
JAMA. 2013;309(12):1207. doi:10.1001/jama.2012.145314
×